EAST RUTHERFORD, N.J., Oct. 17, 2024 /PRNewswire/ — Cambrex, a chief world promise construction and production group (CDMO), these days introduced that their steadiness store industry, Q1 Clinical, has opened a untouched cGMP facility in Durham, North Carolina, increasing its capability for environmentally managed steadiness store products and services to the pharmaceutical, clinical tool and lifestyles sciences industries in North The united states.

Strategically situated within the Analysis Triangle Landscape area, the untouched cutting-edge temperature-controlled and monitored store facility supplies 7 ICH steadiness chambers, masking a territory of statuses together with 2-8°C, 25°C/60p.cRH, 30°C/65p.cRH, 30°C/75p.cRH, and 40°C/75p.cRH, in addition to each -20°C and ultra-low (-70°C/-80°C) store statuses. The power’s Analysis Triangle Landscape (RTP) location in North Carolina will grant similar moment and after moment supply throughout america.

Tom Loewald, Cambrex CEO, said, “After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important milestone in the growth of Q1 Scientific.”

Q1 Clinical’s enlargement enhances its present amenities in Waterford, Eire and Liège, Belgium, and is co-located inside Cambrex’s present analytical products and services web site in Durham. 

Stephen Delaney, Managing Director of Q1 Clinical, added, “With the capabilities and expertise co-located in Durham, we can now deliver services beyond stability storage, such as stability testing and other analytical services for clinical and commercial products.”

Cambrex continues to amplify its functions and capability throughout its North American and Ecu community to satisfy the rising call for for outsourced drug construction and production products and services.

About Cambrex

Cambrex is a chief world promise construction and production group (CDMO) that gives drug substance construction and production throughout all of the drug lifecycle, in addition to complete analytical and IND enabling products and services.

With over 40 years of enjoy and a workforce of two,000 professionals servicing world purchasers from North The united states and Europe, Cambrex trade in a territory of specialised drug substance applied sciences and functions, together with steady wave, managed ingredients, solid-state science, subject matter characterization, and extremely potent APIs.

About Q1 Clinical, a Cambrex corporate

Q1 Clinical, a Cambrex Corporate, is a chief supplier of environmentally managed steadiness store products and services for the pharmaceutical, clinical tool and lifestyles sciences industries. With a decade of experience, Q1 Clinical safeguards important breakthroughs and life-changing inventions at cutting-edge amenities in Eire and Belgium. Through the use of Q1 Clinical’s products and services, firms can boost up the advent of untouched medicine to the marketplace pace heading off the expense of establishing and tracking their very own store chambers. In June 2022, Q1 Clinical was once obtained Cambrex.

Emblem – https://mma.prnewswire.com/media/2236065/Cambrex_logo.jpg
Emblem – https://mma.prnewswire.com/media/1830431/Q1_Scientific_Cambrex_Logo.jpg

SOURCE Cambrex

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Virtual Media
Shops

270k+
Newshounds
Opted In